Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Number of holders
-
17
-
Total 13F shares, excl. options
-
7.54M
-
Shares change
-
-75.1K
-
Total reported value, excl. options
-
$23.3M
-
Value change
-
-$324K
-
Number of buys
-
4
-
Number of sells
-
-9
-
Price
-
$3.09
Significant Holders of LONGBOARD PHARMACEUTICALS, INC. - Common Stock, par value $0.0001 per share (LBPH) as of Q2 2022
19 filings reported holding LBPH - LONGBOARD PHARMACEUTICALS, INC. - Common Stock, par value $0.0001 per share as of Q2 2022.
LONGBOARD PHARMACEUTICALS, INC. - Common Stock, par value $0.0001 per share (LBPH) has 17 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 7.54M shares
.
Largest 10 shareholders include Cormorant Asset Management, LP (2.27M shares), PRICE T ROWE ASSOCIATES INC /MD/ (1.51M shares), MILLENNIUM MANAGEMENT LLC (1.04M shares), FMR LLC (892K shares), FARALLON CAPITAL MANAGEMENT LLC (811K shares), CITIGROUP INC (325K shares), VANGUARD GROUP INC (304K shares), ORBIMED ADVISORS LLC (114K shares), BRIDGEWAY CAPITAL MANAGEMENT, LLC (70K shares), and Integral Health Asset Management, LLC (57.3K shares).
This table shows the top 17 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.